Functional heterogeneity of endothelial P2 purinoceptors in the cerebrovascular tree of the rat
- 1 September 1999
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 277 (3) , H893-H900
- https://doi.org/10.1152/ajpheart.1999.277.3.h893
Abstract
The effects of stimulating P2Y1 or P2Y2 purinoceptors on the endothelium of isolated middle cerebral arteries (MCAs), third-order branches of the MCA (bMCAs), and penetrating arterioles (PAs) of the rat were studied. After pressurization and development of spontaneous tone (25% contraction), resting diameters for MCAs, bMCAs, and PAs were 203 ± 5 ( n = 50), 99 ± 2 ( n = 42), and 87 ± 2 μm ( n = 53), respectively. Luminal application of the P2Y1-selective agonist 2-methylthioadenosine 5′-triphosphate elicited dose-dependent dilations (or loss of intrinsic tone) in MCAs but not in bMCAs or PAs. The dilation in MCAs was completely blocked by removal of the endothelium or by nitro-l-arginine methyl ester (10−5 M), an inhibitor of NO synthase. Luminal application of the P2Y2-selective agonist ATP elicited dilations in MCAs, bMCAs, and PAs. Removal of the endothelium abolished the dilations in all vessel groups. Dilations in MCAs have been shown to involve both NO and endothelium-derived hyperpolarizing factor (EDHF). The dilations in bMCAs and PAs had a minor NO component and prominent EDHF component; that is, 1) the dilations to ATP were not diminished by the combined inhibition of NO synthase and cyclooxygenase, 2) the dilations were accompanied by significant hyperpolarizations of the vascular smooth muscle (∼15 mV), and 3) the dilations were completely abolished by the calcium-activated potassium channel blocker charybdotoxin. We concluded that the role of NO in purinoceptor-induced dilations diminishes along the cerebrovascular tree in the rat, whereas the role of EDHF becomes more prominent.Keywords
This publication has 23 references indexed in Scilit:
- P 2u Receptor–Mediated Release of Endothelium-Derived Relaxing Factor/Nitric Oxide and Endothelium-Derived Hyperpolarizing Factor From Cerebrovascular Endothelium in RatsStroke, 1999
- Endothelium-derived hyperpolarizing factor(s): updating the unknownTrends in Pharmacological Sciences, 1997
- An Endogenous Cannabinoid as an Endothelium-Derived VasorelaxantBiochemical and Biophysical Research Communications, 1996
- ENDOTHELIUM‐DERIVED HYPERPOLARIZING FACTORClinical and Experimental Pharmacology and Physiology, 1996
- Stimulation of α2Adrenoceptors Dilates the Rat Middle Cerebral ArteryAnesthesiology, 1996
- G protein-coupled P2 purinoceptors: from molecular biology to functional responsesTrends in Pharmacological Sciences, 1995
- Purinoceptors: Are there families of P2X and P2Y purinoceptors?Pharmacology & Therapeutics, 1994
- Endothelium Dependent Dilation by Purines of Mouse Brain Arteriolesin vivoEndothelium, 1994
- Endothelium-derived relaxing factor in brain blood vessels is not nitric oxide.Stroke, 1992
- Endothelium-Dependent Responses of Cerebral Arterioles to Adenosine 5’-DiphosphateJournal of Vascular Research, 1992